US Broker Ratings

Novavax, Inc. (NVAX) Stock Analysis: Assessing a 40.92% Potential Upside in the Biotech Sector

Investors keen on exploring opportunities in the biotechnology sector should consider Novavax, Inc. (NASDAQ: NVAX), a company renowned for its innovative vaccine technologies. Headquartered in Gaithersburg, Maryland, Novavax is at..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Exploring Upside Potential with a 16.80% Revenue Growth

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) presents an intriguing opportunity for investors interested in the healthcare sector, particularly within the medical care facilities industry. This Atlanta-based company, with a market..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: Unpacking a 47% Upside Potential

Investors with an eye for growth opportunities in the biotech sector might find Xenon Pharmaceuticals Inc. (NASDAQ: XENE) an intriguing prospect. With a market cap of $2.88 billion and a..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: A 25% Potential Upside Awaits Investors

Amneal Pharmaceuticals, Inc. (AMRX), a prominent player in the healthcare sector, is garnering attention from investors with a tantalizing 25% potential upside. As a global biopharmaceutical company headquartered in Bridgewater,..

89bio, Inc. (ETNB) Stock Analysis: Exploring a 125% Potential Upside in Clinical-Stage Biotech

89bio, Inc. (NASDAQ: ETNB) is capturing the attention of investors with its promising pipeline in the biotechnology sector. This clinical-stage biopharmaceutical company, established in 2018 and based in San Francisco,..

ImmunityBio, Inc. (IBRX) Stock Analysis: Unpacking a 282% Potential Upside

ImmunityBio, Inc. (NASDAQ: IBRX), a key player in the biotechnology sector, is garnering considerable attention from investors due to its robust growth potential and promising therapeutic developments. With a market..

Arcellx, Inc. (ACLX) Stock Analysis: Biotechnology Innovator with 44.55% Upside Potential

Arcellx, Inc. (NASDAQ: ACLX), a promising player in the biotechnology sector, is capturing the attention of investors with its innovative approach to immunotherapy. Operating out of Redwood City, California, this..

U.S. Physical Therapy, Inc. (USPH) Investor Outlook: Unpacking a 33.97% Potential Upside

U.S. Physical Therapy, Inc. (NYSE: USPH) is carving a niche in the healthcare sector, specifically within the medical care facilities industry. Based in Houston, Texas, and with a market capitalization..

Clover Health Investments, Corp (CLOV): Investor Outlook Highlights 21.67% Potential Upside

Clover Health Investments, Corp (CLOV) is a notable player in the healthcare sector, specifically within the healthcare plans industry. Based in Wilmington, Delaware, Clover Health focuses on providing Medicare Advantage..

MannKind Corporation (MNKD) Stock Analysis: Exploring an 89.79% Potential Upside in Biotech Innovation

MannKind Corporation (NASDAQ: MNKD), a prominent player in the healthcare sector, focuses on the development and commercialization of therapeutic products for endocrine and orphan lung diseases. With a market capitalization..

GoodRx Holdings, Inc. (GDRX) Investor Outlook: Exploring a 31.89% Potential Upside

GoodRx Holdings, Inc. (NASDAQ: GDRX) presents a compelling case for investors seeking opportunities in the healthcare sector, particularly within the health information services industry. With a market capitalization of $1.41..

Sotera Health Company (SHC) Stock Analysis: Navigating Growth in the Diagnostics & Research Sector

Sotera Health Company (NASDAQ: SHC) stands out in the healthcare sector, specifically within the diagnostics and research industry, with a market capitalization of $4.58 billion. As a provider of sterilization,..

Kiniksa Pharmaceuticals, Ltd. (KNSA) Stock Analysis: Strong Buy Ratings and 28.88% Potential Upside for Investors

Kiniksa Pharmaceuticals, Ltd. (KNSA), a standout player in the healthcare sector, is making significant strides in the drug manufacturing industry with a focus on specialty and generic pharmaceuticals. Based in..

Apogee Therapeutics, Inc. (APGE) Investor Outlook: 157.84% Potential Upside in the Biotech Frontier

Apogee Therapeutics, Inc. (NASDAQ: APGE) is capturing the attention of investors with its robust pipeline in the biotechnology sector, aiming to address various inflammatory and immunology indications. With a market..

UFP Technologies, Inc. (UFPT) Stock Analysis: Unlocking a 68.46% Potential Upside

For investors seeking opportunities in the healthcare sector, UFP Technologies, Inc. (NASDAQ: UFPT) presents an intriguing prospect with a significant potential upside. With its focus on designing and manufacturing solutions..

Acadia Healthcare (ACHC) Stock Analysis: A 31.56% Upside Amidst Healthcare Sector Volatility

Acadia Healthcare Company, Inc. (NASDAQ: ACHC), a pivotal player in the behavioral healthcare services landscape, offers a compelling narrative for investors navigating the complex healthcare sector. With a market capitalization..

Innoviva, Inc. (INVA) Stock Analysis: Unpacking a 115% Potential Upside in Biotech

Innoviva, Inc. (NASDAQ: INVA), a biopharmaceutical company, is making significant waves in the healthcare sector with its promising portfolio and strong market potential. With a market capitalization of $1.2 billion,..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: Exploring a Potential 117% Upside in the Biotech Sector

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is capturing the attention of investors with a compelling potential upside of 117.45%. As a specialized player in the biotechnology sector, BioCryst focuses on developing..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Unlocking a Potential 126% Upside in Biotech Innovations

Celldex Therapeutics, Inc. (NASDAQ: CLDX) stands at the forefront of biopharmaceutical innovation, with a focus on therapeutic antibodies for severe inflammatory, allergic, and autoimmune diseases. As investors look for growth..

Enovis Corporation (ENOV) Stock Analysis: Exploring a 53.53% Potential Upside in the Medical Device Industry

Investors looking for opportunities in the healthcare sector might want to pay close attention to Enovis Corporation (ENOV), a prominent player in the medical device industry. With a market capitalization..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds